Read More Pharma Industry News LIXTE Biotechnology commences Phase 1b/2 clinical trial in ovarian cancer LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) has initiated a pivotal Phase 1b/2 clinical trial, in partnership… byPallavi MadhirajuJanuary 29, 2024